Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teuvo L Tammela

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Cancer Care|June 22, 2017
Experiences and psychological distress of spouses of prostate cancer patients at time of diagnosis and primary treatmentUlla-Sisko Lehto, Arpo Aromaa, Teuvo L Tammela
European Urology Focus|August 15, 2017
Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer CentresLasse Saarimäki, Jonas Hugosson, Teuvo L Tammela, et al.
Scandinavian Journal of Urology|March 19, 2013
Side-fenestrated catheter decreases leakage at the urethrovesical anastomosis after robot-assisted laparoscopic radical prostatectomyJarno Riikonen, Antti Kaipia, Mika Matikainen, et al.
World Journal of Urology|February 26, 2015
Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPHNadir I Osman, Christopher R Chapple, Teuvo L Tammela, et al.
Clinical Epidemiology|November 8, 2019
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over TimeJuho Pylväläinen, Kirsi Talala, Teemu Murtola, et al.
Urologic Oncology|June 3, 2017
Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancerJukka Kallio, Mari Hämäläinen, Tiina Luukkaala, et al.
European Urology|May 24, 2016
Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer StudyTomi Pakarainen, Jani Raitanen, Kirsi Talala, et al.
European Urology Focus|July 30, 2017
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR TrialsNeal D Shore, Teuvo L Tammela, Christophe Massard, et al.
International Journal of Cancer|October 3, 2014
Family history in the Finnish Prostate Cancer Screening TrialLasse Saarimäki, Teuvo L Tammela, Liisa Määttänen, et al.
BJU International|June 3, 2011
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)J Curtis Nickel, Peter Gilling, Teuvo L Tammela, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Cancer Care|June 22, 2017
Experiences and psychological distress of spouses of prostate cancer patients at time of diagnosis and primary treatmentUlla-Sisko Lehto, Arpo Aromaa, Teuvo L Tammela
European Urology Focus|August 15, 2017
Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer CentresLasse Saarimäki, Jonas Hugosson, Teuvo L Tammela, et al.
Scandinavian Journal of Urology|March 19, 2013
Side-fenestrated catheter decreases leakage at the urethrovesical anastomosis after robot-assisted laparoscopic radical prostatectomyJarno Riikonen, Antti Kaipia, Mika Matikainen, et al.
World Journal of Urology|February 26, 2015
Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPHNadir I Osman, Christopher R Chapple, Teuvo L Tammela, et al.
Clinical Epidemiology|November 8, 2019
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over TimeJuho Pylväläinen, Kirsi Talala, Teemu Murtola, et al.
Urologic Oncology|June 3, 2017
Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancerJukka Kallio, Mari Hämäläinen, Tiina Luukkaala, et al.
European Urology|May 24, 2016
Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer StudyTomi Pakarainen, Jani Raitanen, Kirsi Talala, et al.
European Urology Focus|July 30, 2017
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR TrialsNeal D Shore, Teuvo L Tammela, Christophe Massard, et al.
International Journal of Cancer|October 3, 2014
Family history in the Finnish Prostate Cancer Screening TrialLasse Saarimäki, Teuvo L Tammela, Liisa Määttänen, et al.
BJU International|June 3, 2011
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)J Curtis Nickel, Peter Gilling, Teuvo L Tammela, et al.
Pageof 6